In defence of the decriminalisation of drug possession in the UK
Research
Drug Science publishes peer reviewed research, reports, and articles to provide clear, evidence-based information without political or commercial interference.
- Mar 20
- 1 min
Childhood trauma, challenging experiences, and post traumatic growth in ayahuasca use
- Feb 28
- 2 min
Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study
- Feb 22
- 1 min
A history of the European Medical Society for Psycholytic Therapy (EPT) 1964–1974
- Jan 31
- 2 min
Investigation of the household storage of medicines and disposal practices in Parklands sub-county in Nairobi, Kenya
- Jan 9
- 1 min
Minorities’ diminished psychedelic returns: Cardio-metabolic health
- Nov 21, 2023
- 1 min
Counting and accounting for drug-related deaths at UK music festivals 2017–2023: A commentary
- Nov 19, 2023
- 2 min
Decrypting the cryptomarkets: Trends over a decade of the Dark Web drug trade
- Nov 16, 2023
- 2 min
The impact of over the counter and prescription medication misuse on friends and family
- Sep 7, 2023
- 1 min
From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
- Sep 6, 2023
- 1 min
Racial and religious motives for drug criminalization
- Sep 2, 2023
- 1 min
MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians
- Sep 1, 2023
- 2 min
Perceived barriers to access to hepatitis C for people who inject drugs in Morocco: A qualitative explorative study
- Jul 31, 2023
- 1 min
Could classic psychedelics influence immigrants’ acculturation process? A narrative review contemplating how
- Jul 31, 2023
- 1 min
A phenomenological analysis of Fellini's films to understand the effect of LSD therapy on his creativity
- Jul 10, 2023
- 2 min
Impact of the introduction of medical cannabis in the UK on risk perception and recreational use of cannabis: A longitudinal and cross-sectional analysis
- Jun 23, 2023
- 1 min
Minorities’ diminished psychedelic returns
- Jun 6, 2023
- 1 min
Italian psychedelic therapies of the past century: An historical overview
- Jun 2, 2023
- 2 min
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model
- May 25, 2023
- 2 min
Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life
- May 25, 2023
- 1 min
Does the co-use of cannabis exacerbate the effect of alcohol on the risk of crashing? A systematic review and meta-analysis
- May 11, 2023
- 2 min
ARC: a framework for access, reciprocity and conduct in psychedelic therapies
- May 5, 2023
- 2 min
Characteristics of and 3-month health outcomes for people seeking treatment with prescribed cannabis
- Apr 26, 2023
- 1 min
A roadmap for psychedelic pharmacy in Canada
- Apr 11, 2023
- 1 min
Decriminalisation of drug possession in Oregon: Analysis and early lessons
- Apr 6, 2023
- 2 min
The use of chlordiazepoxide for outpatient gamma-butyrolactone (GBL) detoxification: An observational study
- Mar 14, 2023
- 2 min
Medication sparing after medical cannabis initiation: A case study of a chronic pain patient in T21
- Nov 14, 2022
- 1 min
The United Kingdom's Psychoactive Substances Act 2016. Where are we now?
- Oct 26, 2022
- 2 min
Examining the gender dimension in the non-medical use of over the counter and prescription only medication
- Oct 2, 2022
- 1 min
Psychedelic use predicts objective knowledge about climate change via increases in nature relatedness
- Sep 23, 2022
- 2 min
A comparative study of the harms of nitrous oxide and poppers using the MCDA approach
- Sep 7, 2022
- 1 min
An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma
- Aug 15, 2022
- 2 min
How to read a paper on the short-term impairing effects of cannabis: A selective and critical review of the literature
- Jul 25, 2022
- 2 min
Comparative harms assessments for cannabis, alcohol, and tobacco: Risk for psychosis, cognitive impairment, and traffic accident
- Jul 25, 2022
- 1 min
State naloxone co-prescribing laws show mixed effects on overdose mortality rates
- Jul 18, 2022
- 1 min
Eating ourselves to death: How food is a drug and what food abuse costs
- Jul 11, 2022
- 1 min
The Misuse of Drugs Regulations 2001: A case study in poor legislative drafting
- May 20, 2022
- 2 min
A critical review of drug testing policy in the Philippines
- May 18, 2022
- 2 min
Psychedelics as potential catalysts of scientific creativity and insight
- May 11, 2022
- 2 min
Farmability and pharmability: Transforming the drug market to a health-and human rights-centred approach from self-cultivation to safe supply of controlled substances
- Apr 29, 2022
- 2 min
Regulating the oxides of nitrogen – popping the myths
- Mar 16, 2022
- 2 min
Can psilocybin be safely administered under medical supervision? A systematic review of adverse event reporting in clinical trials
- Dec 14, 2021
- 4 min
How does cannabis affect road crash risk? A systematic review and meta-analyses
- Nov 29, 2021
- 2 min
Professional Perspectives on Treatment for Substance Use Disorders with Mental Health Problems
- Oct 26, 2021
- 3 min
Schedule 1 Barriers to Research in the UK: An In-depth Qualitative Analysis
- Oct 18, 2021
- 2 min
The Cocaine Vape - A concept of a harm reduction device for current users of smokable cocaine forms
- Sep 6, 2021
- 1 min
Facing drug addiction: Vietnam’s struggle with opioids
- Aug 26, 2021
- 2 min
“We're asking for quality of life for our children” - Medical cannabis and epilepsy in the UK: A qualitative analysis of the carers’ perspective
- Aug 9, 2021
- 3 min
Developing a Model for a Legal Cannabis Market in the UK
- Jul 26, 2021
- 1 min
Managing kratom dependency with Buprenorphine during covid-19: A case report
Medicinal cannabis for treating PTSD and comorbid depression: Real World Evidence from Project T21
- Aug 31, 2023
- 1 min
Cannabis-based medicinal products for the treatment of Long COVID symptoms: current and potential applications
- Aug 21, 2023
- 7 min
A drug harms ranking study for Aotearoa New Zealand
- Jul 17, 2023
- 1 min
Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins
- Jun 12, 2023
- 1 min
Psychedelic therapy in the treatment of addiction: the past, present and future
- Mar 23, 2023
- 2 min
Preliminary findings from T21 Australia
- Nov 3, 2022
- 4 min
The value of real world evidence: The case of medical cannabis
- Jul 7, 2022
- 32 min
User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study
- Jun 21, 2022
- 2 min
Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research
- Jun 13, 2022
- 3 min
Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21
- May 6, 2022
- 1 min
The UK's first unsanctioned overdose prevention site; A proof-of-concept evaluation
- Feb 3, 2022
- 3 min
Are psychedelics dangerous? - What the research says
- Dec 15, 2021
- 2 min
Medical cannabis for severe treatment resistant epilepsy in children: a case series of 10 patients
- May 18, 2021
- 2 min
Controversies in Medical Cannabis
- Mar 2, 2021
- 2 min
Psychedelic Microdosing - Just a Placebo Effect?
- Feb 17, 2021
- 2 min
Medical cannabis dependence: A critical review of issues and evidence
- Sep 22, 2020
- 2 min
So near yet so far: why won’t the UK prescribe medical cannabis?
- Aug 20, 2020
- 2 min
Medical cannabis in the UK: From principle to practice
- Jul 22, 2019
- 2 min
First safety study of MDMA-assisted psychotherapy in patients with alcohol use disorder
- Apr 5, 2018
- 3 min
New analysis of alcohol and cannabis – what’s the harm?
- Mar 3, 2016
- 1 min
Ketamine as an essential medicine
- Apr 3, 2011
- 1 min
Drug Science ketamine review
- Apr 3, 2010
- 3 min
MCDA Comparison of Drug and Alcohol Harms in the UK
- Jan 10
- 2 min
Overdose Prevention Centres, Safe Consumption Sites, and Drug Consumption Rooms: A Rapid Evidence Review
- Dec 11, 2023
- 5 min
Psilocybin for Existential Distress
- Nov 2, 2023
- 1 min
Know Your Rights: Medical Cannabis
- Oct 27, 2022
- 4 min
The Case for Overdose Prevention Centres in the UK - An Evidence-based approach
- Jun 4, 2021
- 7 min
YouGov Results - Is the UK Ready to Reschedule Psilocybin?
- Apr 3, 2016
- 1 min
Expert Report on cannabis legalisation for the Liberal Democrats
- Apr 3, 2016
- 3 min
Cannabis Review for the attention of the WHO